First Results of Concurrent Chemoradiation with Two Courses of 5 × 25 mg/m(2) Cisplatin for Locally Advanced Head and Neck Cancer

por Zwaan, Inga, Soror, Tamer, Idel, Christian, Pries, Ralph, Bruchhage, Karl L., Hakim, Samer G., Yu, Nathan Y., Rades, Dirk
Publicado 2023

Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)

por Rades, Dirk, Zwaan, Inga, Soror, Tamer, Idel, Christian, Pries, Ralph, Bruchhage, Karl L., Hakim, Samer G., Yu, Nathan Y.
Publicado 2023

A New Prognostic Instrument for Predicting the Probability of Completion of Cisplatin during Chemoradiation for Head and Neck Cancer

por Rades, Dirk, Zwaan, Inga, Idel, Christian, Pries, Ralph, Bruchhage, Karl L., Hakim, Samer G., Yu, Nathan Y., Soror, Tamer
Publicado 2023

Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer – results of a randomized phase III trial (RAREST-02)

por Rades, Dirk, Zwaan, Inga, Cacicedo, Jon, Bruchhage, Karl L., Hakim, Samer G., Olbrich, Denise, Schild, Steven E., Tvilsted, Soeren, Janssen, Stefan
Publicado 2022